Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study

The goal of STAGE I of the CMV TransmIT Study is to determine the prevalence of CMV shedding in children up to and including 36 months of age in large group childcare centers and in staff who regularly work at the center. Participants will complete a health survey and provide one saliva sample for CMV PCR testing. In addition, infrastructure for the study will be developed (e.g. community engagement to build the network of centers, data pipelines, digital platform, sampling workflows) and participant sample collection at home will be piloted. These activities will inform the design of STAGE II.

NCT Number	NCT06522880
Lead Sponsor	University of Massachusetts, Worcester Collaborators: ModernaTX, Inc.
Conditions	Cytomegalovirus Infections
Enrollment	100 participants
Start Date	2023-08-10
Primary Completion	2027-01-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-07-26